JP2025511183A5 - - Google Patents
Info
- Publication number
- JP2025511183A5 JP2025511183A5 JP2024558017A JP2024558017A JP2025511183A5 JP 2025511183 A5 JP2025511183 A5 JP 2025511183A5 JP 2024558017 A JP2024558017 A JP 2024558017A JP 2024558017 A JP2024558017 A JP 2024558017A JP 2025511183 A5 JP2025511183 A5 JP 2025511183A5
- Authority
- JP
- Japan
- Prior art keywords
- modified oligonucleotide
- item
- compound according
- modified
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263326733P | 2022-04-01 | 2022-04-01 | |
| US63/326,733 | 2022-04-01 | ||
| US202263407071P | 2022-09-15 | 2022-09-15 | |
| US63/407,071 | 2022-09-15 | ||
| PCT/US2023/017185 WO2023192630A2 (en) | 2022-04-01 | 2023-03-31 | Angiotensinogen-modulating compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511183A JP2025511183A (ja) | 2025-04-15 |
| JP2025511183A5 true JP2025511183A5 (cg-RX-API-DMAC7.html) | 2026-04-08 |
Family
ID=88203363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558017A Pending JP2025511183A (ja) | 2022-04-01 | 2023-03-31 | アンジオテンシノーゲンを調節する組成物及びその使用方法 |
Country Status (14)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240401045A1 (en) * | 2021-10-01 | 2024-12-05 | Adarx Pharmaceuticals, Inc. | Angiotensinogen-modulating compositions and methods of use thereof |
| IL312811A (en) * | 2021-11-16 | 2024-07-01 | Shanghai Argo Biopharmaceutical Co Ltd | Composition and method for inhibiting angiotensinogen (agt) protein expression |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050287570A1 (en) * | 2004-05-26 | 2005-12-29 | Wyeth | Probe arrays for expression profiling of rat genes |
| WO2011156734A2 (en) * | 2010-06-11 | 2011-12-15 | Hitachi Chemical Co., Ltd. | Method of characterizing vascular diseases |
| WO2014018930A1 (en) * | 2012-07-27 | 2014-01-30 | Isis Pharmaceuticals. Inc. | Modulation of renin-angiotensin system (ras) related diseases by angiotensinogen |
| TWI851574B (zh) * | 2018-05-14 | 2024-08-11 | 美商阿尼拉製藥公司 | 血管收縮素原（ＡＧＴ）ｉＲＮＡ組成物及其使用方法 |
-
2023
- 2023-03-31 US US18/194,203 patent/US20240041913A1/en active Pending
- 2023-03-31 KR KR1020247036043A patent/KR20240168424A/ko active Pending
- 2023-03-31 TW TW112112620A patent/TW202405171A/zh unknown
- 2023-03-31 EP EP23781897.6A patent/EP4504937A2/en active Pending
- 2023-03-31 WO PCT/US2023/017185 patent/WO2023192630A2/en not_active Ceased
- 2023-03-31 CA CA3255793A patent/CA3255793A1/en active Pending
- 2023-03-31 PE PE2024002116A patent/PE20242356A1/es unknown
- 2023-03-31 IL IL315862A patent/IL315862A/en unknown
- 2023-03-31 JP JP2024558017A patent/JP2025511183A/ja active Pending
- 2023-03-31 CN CN202380037505.2A patent/CN119137272A/zh active Pending
- 2023-03-31 AU AU2023245480A patent/AU2023245480A1/en active Pending
-
2024
- 2024-09-27 CL CL2024002910A patent/CL2024002910A1/es unknown
- 2024-09-30 CO CONC2024/0013353A patent/CO2024013353A2/es unknown
- 2024-09-30 MX MX2024012080A patent/MX2024012080A/es unknown